{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:16:59Z","timestamp":1791461819222,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.acvd.2024.07.059","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T12:11:26Z","timestamp":1722946286000},"page":"569-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort"],"prefix":"10.1016","volume":"117","author":[{"given":"David","family":"Sulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Beaupr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Procopi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Kerneis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Guedeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Elhadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rouanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Brugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Hekimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Chommeloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2024.07.059_bib0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ehf2.13734","article-title":"Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry","volume":"9","author":"Delmas","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0155","doi-asserted-by":"crossref","first-page":"e021061","DOI":"10.1161\/JAHA.121.021061","article-title":"Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States","volume":"10","author":"Osman","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2024.07.059_bib0160","doi-asserted-by":"crossref","first-page":"e008141","DOI":"10.1161\/CIRCHEARTFAILURE.120.008141","article-title":"Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock: results from the RESCUE registry","volume":"14","author":"Yang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.07.059_bib0170","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.07.059_bib0175","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/ejhf.2274","article-title":"Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials","volume":"23","author":"Schrage","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0180","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"Naidu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.07.059_bib0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.acvd.2019.02.001","article-title":"Design and preliminary results of FRENSHOCK 2016: a prospective nationwide multicentre registry on cardiogenic shock","volume":"112","author":"Delmas","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2024.07.059_bib0190","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ehf2.13202","article-title":"Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0195","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ejhf.1566","article-title":"Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study","volume":"21","author":"Helgestad","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ejhf.339","article-title":"Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes","volume":"17","author":"De Luca","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2024.07.059_bib0205","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.acvd.2023.06.008","article-title":"Cardiogenic shock in adults with congenital heart disease: insights from the FRENSHOCK registry","volume":"116","author":"Karsenty","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2024.07.059_bib0210","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2024.07.059_bib0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2024.07.059_bib0220","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","article-title":"Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery","volume":"376","author":"Mehta","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.07.059_bib0225","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.07.059_bib0230","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.07.059_bib0235","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2024.07.059_bib0240","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2023.06.026","article-title":"Long-term outcomes of cardiogenic shock complicating myocardial infarction","volume":"82","author":"Sterling","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2024.07.059_bib0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/HCO.0000000000000957","article-title":"The landscape of cardiogenic shock: epidemiology and current definitions","volume":"37","author":"Palacios Ordonez","year":"2022","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.acvd.2024.07.059_bib0250","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2024.07.059_bib0255","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2024.07.059_bib0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.acvd.2022.10.007","article-title":"Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: insight from the ePARIS registry","volume":"116","author":"Suc","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2024.07.059_bib0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.acvd.2024.01.006","article-title":"Cardiogenic shock and chronic kidney disease: dangerous liaisons","volume":"117","author":"Cherbi","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2024.07.059_bib0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/CCM.0b013e31829f6242","article-title":"Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock","volume":"42","author":"van Diepen","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.acvd.2024.07.059_bib0275","doi-asserted-by":"crossref","first-page":"e030975","DOI":"10.1161\/JAHA.123.030975","article-title":"Optimal heart failure medical therapy and mortality in survivors of cardiogenic shock: insights from the FRENSHOCK registry","volume":"13","author":"Matsushita","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2024.07.059_bib0280","doi-asserted-by":"crossref","first-page":"e008235","DOI":"10.1161\/JAHA.117.008235","article-title":"Prevalence, causes, and predictors of 30-day readmissions following hospitalization with acute myocardial infarction complicated by cardiogenic shock: findings from the 2013\u20132014 national readmissions database","volume":"7","author":"Mahmoud","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624002808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213624002808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:55:09Z","timestamp":1759352109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213624002808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1875213624002808"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2024.07.059","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2024.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}